Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Operating Expenses (2016 - 2025)

STRATA Skin Sciences' Operating Expenses history spans 13 years, with the latest figure at $5.4 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 38.64% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $20.0 million, down 15.33%, while the annual FY2024 figure was $28.3 million, 4.7% up from the prior year.
  • Operating Expenses for Q3 2025 was $5.4 million at STRATA Skin Sciences, down from $6.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $8.2 million in Q4 2023 and bottomed at $2.6 million in Q4 2024.
  • The 5-year median for Operating Expenses is $6.1 million (2021), against an average of $6.0 million.
  • The largest annual shift saw Operating Expenses skyrocketed 58.82% in 2021 before it crashed 68.88% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $6.6 million in 2021, then rose by 1.39% to $6.7 million in 2022, then grew by 22.76% to $8.2 million in 2023, then plummeted by 68.88% to $2.6 million in 2024, then surged by 108.85% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Operating Expenses are $5.4 million (Q3 2025), $6.6 million (Q2 2025), and $5.5 million (Q1 2025).